Neoplasms, Hematologic Recruiting Phase 1 / 2 Trials for Sirolimus (DB00877)

Also known as: Hematological Neoplasm / Hematological Neoplasms / Hematologic Neoplasm / Hematologic Neoplasms / Haematological neoplasm / Malignant tumor of lymphoid hemopoietic and related tissue (disorder) / Haematological malignancy / Hematological malignancy / Hematologic neoplasm (disorder)

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05327023Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesTreatment
NCT03983850Optimizing PTCy Dose and TimingTreatment
NCT04959175Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesTreatment